# Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

> **NCT00002616** · PHASE1 · UNKNOWN · sponsor: **University of Illinois at Chicago** · enrollment: 36 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** filgrastim
- **DRUG:** carboplatin
- **DRUG:** cyclophosphamide
- **DRUG:** thiotepa
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00002616
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1995-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002616, "Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00002616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*